Testosterone skin patch dose study in men with low testosterone
Treatments studied
Part of Hormones & metabolism clinical trials.
This Phase 2 trial tests different doses of a testosterone skin patch to see which works best and is absorbed safely. It may help men with low morning testosterone who can meet study requirements like non-smoking and multiple blood draws.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man aged 18 to 75 with low morning testosterone (≤300 ng/dL)
- Have a BMI between 18 and 30
- Be a non-smoker
- Be generally healthy based on exam, ECG (heart tracing), and blood/urine tests
- Be willing to return for all visits and have catheter placement and blood draws on two days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests how well a testosterone skin treatment (testosterone delivered through the skin) works in healthy adults. It also checks how your body absorbs and handles the medicine, using repeated blood draws and on-site visits.
This study examines how testosterone therapy affects blood pressure in men with low testosterone. It uses a 24-hour blood pressure monitor to track changes over time.
This Phase 2 study tests whether testosterone therapy can help men with chronic kidney disease who have low testosterone and related symptoms. It looks to see if treatment is safe and beneficial, while carefully checking heart, blood, prostate, and clotting risks.
This trial tests different doses of insulin delivered through the skin (not a shot) to see how well it controls blood sugar in adults with type 2 diabetes. You may be able to join if your current insulin routine and recent blood sugar patterns fit the study limits.
This trial tests tiny rods placed under the skin that slowly release testosterone to treat low testosterone symptoms. It's for men who have consistently low testosterone levels and are not planning to have children.
This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are not receiving active treatment. You may be eligible if you have confirmed low testosterone and are being monitored without intervention.
Hear when a new Hypogonadotropism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.